Literature DB >> 10647898

Genes and chromosomal breakpoints in the Langer-Giedion syndrome region on human chromosome 8.

H J Lüdecke1, O Schmidt, J Nardmann, D von Holtum, P Meinecke, M Muenke, B Horsthemke.   

Abstract

The tricho-rhino-phalangeal syndrome type II (TRPS II, or Langer-Giedion syndrome) is an example of contiguous gene syndromes, as it comprises the clinical features of two autosomal dominant diseases, TRPS I and a form of multiple cartilaginous exostoses caused by mutations in the EXT1 gene. We have constructed a contig of cosmid, lambda-phage, PAC, and YAC clones, which covers the entire TRPS I critical region. Using these clones we identified a novel submicroscopic deletion in a TRPS I patient and refined the proximal border of the minimal TRPS1 gene region by precisely mapping the inversion breakpoint of another patient. As a first step towards a complete inventory of genes in the Langer-Giedion syndrome chromosome region (LGCR) with the ultimate aim to identify the TRPS1 gene, we analyzed 23 human expressed sequence tags (ESTs) and four genes (EIF3S3, RAD21, OPG, CXIV) which had been assigned to human 8q24.1. Our analyses indicate that the LGCR is gene-poor, because none of the ESTs and genes map to the minimal TRPS1 gene region and only two of these genes, RAD21 and EIF3S3, are located within the shortest region of deletion overlap of TRPS II patients. Two genes, OPG and CXIV, which are deleted only in some patients with TRPS II may contribute to the clinical variability of this syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10647898     DOI: 10.1007/s004399900176

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III.

Authors:  H J Lüdecke; J Schaper; P Meinecke; P Momeni; S Gross; H Hirche; M J Abramowicz; B Albrecht; C Apacik; H J Christen; U Claussen; K Devriendt; E Fastnacht; A Forderer; U Friedrich; T H Goodship; M Greiwe; H Hamm; R C Hennekam; G K Hinkel; M Hoeltzenbein; H Kayserili; F Majewski; M Mathieu; R McLeod; A T Midro; U Moog; T Nagai; N Niikawa; K H Orstavik; E Plöchl; C Seitz; J Schmidtke; L Tranebjaerg; M Tsukahara; B Wittwer; B Zabel; G Gillessen-Kaesbach; B Horsthemke
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

2.  Mixed Phenotype of Langer-Giedion's and Cornelia de Lange's Syndromes in an 8q23.3-q24.1 Microdeletion without TRPS1 Deletion.

Authors:  Ana Herrero-García; Purificación Marín-Reina; Gloria Cabezuelo-Huerta; M Belén Ferrer-Lorente; Mónica Rosello; Carmen Orellana; Francisco Martínez; Antonio Pérez-Aytés
Journal:  J Pediatr Genet       Date:  2019-09-03

3.  A central role for TRPS1 in the control of cell cycle and cancer development.

Authors:  Lele Wu; Yuzhi Wang; Yan Liu; Shiyi Yu; Hao Xie; Xingjuan Shi; Sheng Qin; Fei Ma; Tuan Zea Tan; Jean Paul Thiery; Liming Chen
Journal:  Oncotarget       Date:  2014-09-15

4.  High grade osteosarcoma on a background of trichorhinophalangeal syndrome: A family perspective.

Authors:  Scott Evans; Paul Brewer; Sumathi Vaiyapuri; Robert Grimer
Journal:  J Bone Oncol       Date:  2013-04-22       Impact factor: 4.072

5.  TRPS1 mutation detection in Chinese patients with Tricho-rhino-phalangeal syndrome and identification of four novel mutations.

Authors:  Chen Wang; Yufei Xu; Yanrong Qing; Ruen Yao; Niu Li; Xiumin Wang; Tingting Yu; Jian Wang
Journal:  Mol Genet Genomic Med       Date:  2020-08-10       Impact factor: 2.183

6.  An interstitial deletion at 8q23.1-q24.12 associated with Langer-Giedion syndrome/ Trichorhinophalangeal syndrome (TRPS) type II and Cornelia de Lange syndrome 4.

Authors:  Nikoletta Selenti; Maria Tzetis; Maria Braoudaki; Krinio Gianikou; Sofia Kitsiou-Tzeli; Helen Fryssira
Journal:  Mol Cytogenet       Date:  2015-08-12       Impact factor: 2.009

7.  Annular pancreas in Trichorhinophalangeal syndrome type II with 8q23.3-q24.12 interstitial deletion.

Authors:  Qi Li; Zhen Zhang; Yuchun Yan; Ping Xiao; Zhijie Gao; Wei Cheng; Lin Su; Kaihui Yu; Hua Xie; Xiaoli Chen; Qian Jiang; Long Li
Journal:  Mol Cytogenet       Date:  2015-12-15       Impact factor: 2.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.